SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Binford, Jr. who wrote (468)3/25/1998 12:10:00 PM
From: Jim Mac  Read Replies (1) of 1754
 
The FTC is implying Visx and Summit ripped off the myopic public.

Dropping the fee by $150 per procedure is an insignificant reduction compared to the benefits of LVC. Obviously, no one forced any individual to acquire a laser or have the procedure done. They all did it willingly, and dropping the price by $150 wouldn't have had any meaningful effect on procedure growth.

What does FTC think? Visx and Summit would have charged only $100 without PPP, even if they could easily charge $250? It's ludicrous.

On the bright side, this may hasten the dissolution of PPP, to Visx's benefit, and Summit's disadvantage.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext